Beth Israel Medical Center, with over 35 years of leadership in the field of addiction treatment, launched the Chemical Dependency Institute in 1988. The Institute, recently renamed The Baron Edmond de Rothschild Chemical Dependency Institute, comprises a variety of clinical programs that care for some 13,000 individuals yearly; these programs are provided on an inpatient as well as ambulatory basis, and include both long-term rehabilitation as well as acute intervention. They have served as models for clinicians from around the world for over three decades.

The Institute also has an active, highly respected research staff that has published scores of seminal findings in peer-reviewed professional journals. Institute staff members are active participants in international conferences and have played a very strong advocacy role, in America and abroad, for humane policy reform and expansion as well as enhancement of treatment services.

The Edmond de Rothschild Foundation's most recent generosity continues its long tradition of support for Beth Israel Medical Center's patient services.